Ireland
--:--IST
Active, not recruiting Phase 4

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

NCT05603741 · tracked via the Priya Life Science Canada tracker
Phase
Phase 4
Started
2022-11-10
Last updated
2024-12-18

Condition(s) studied

Ehlers-Danlos SyndromeAnesthesia, Local

Investigational drug(s) / intervention(s)

0.9% Sodium Chloride InjectionLidocaine Injection 2% →

0.9% Sodium Chloride Injection: All participants will be injected subcutaneously with a single 0.5ml dose

Lidocaine Injection 2%: All participants will be injected subcutaneously with a single 0.5ml dose

Study summary

Local anesthetic resistance is commonly reported by patients with EDS. However, there are no objective data on the occurrence of local anesthetic resistance in EDS patients and in healthy volunteers. The investigators propose to collect such objective data on the frequency of drug resistance and whether any problems with local anesthesia are due to initial ineffectiveness or due to its effects dissipating too soon.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * EDS patients, clinically diagnosed hypermobile EDS based on 2017 criteria * EDS patients with genetically proven non-hypermobile EDS * Healthy participants, no EDS * Able and willing to provide informed consent Exclusion Criteria: * Known allergy to Lidocaine * Unable to provide informed consent

Primary outcome measure(s)

  • Delta Pain Scores Lidocaine at 5 min [ Time Frame: 5 minutes post-injection ] — 5 minutes post-injection
    Difference between the pain score at the Lidocaine injection locations (compared to a control location) and the saline injection location (compared to a control location). The pain scale is .a 4 level scale from 0 ("absent sensation"), to 1 ("dull pressure"), to 2 ("sharp but less than a control \[non-injected\] region) to 3 (same or worse than the control region).

Trial sites (1)

FacilityCityRegionStatus
Cardiovascular Autonomic Research Lab, University of Calgary Calgary Alberta

Other trials for the same condition

Hypobaric L5-S1 Study Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05603741 on ClinicalTrials.gov ↗ ← All trials in Canada